ACIP ‘Pivot’ May Mean Variable US Coverage For New Vaccines, Higher Copays

Clarity on payer responses to controversial vaccine recommendations from the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices may be coming.

ACIP changes likely will create confusion and access issues among insurers. (Shutterstock)
Key Takeaways
  • Stricter vaccine recommendation decisions by the new ACIP could result in inconsistent coverage policies among private payers, which make up the largest group of payers in the US.

Some private US insurers may avoid covering new vaccines without an official endorsement from the US Centers for Disease Control and Prevention’s reconstituted Advisory Committee on Immunization Practices (ACIP) going forward.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Vaccines

More from United States